HOUSTON, Nov. 3, 2005 (PRIMEZONE) -- Labwire Inc. (Pink Sheets:LBWR), a leading provider of employee screening management solutions, announces that the Company held its initial "Advisory Board" meeting on Friday, October 28, 2005. The board meeting's agenda was to direct the Company's sales and marketing efforts toward targeting specific pre-qualified client prospects within specific industries via contacts provided by Advisory Board members.
Labwire's Advisory Board consists of senior executives from a diverse group of industrial corporations. Members include Garis Smith, President of Olympic Seismic, Charles Rossi, President of Advertising Impact, Paul Brennan, Partner, Industrial Information Resource, Gene Chew, Consultant, Martin Products NNP, and Travis Brunner, Manager, Oilexec Inc.
Dexter Morris, President of Labwire, commented, "Labwire's Advisory Board is comprised of leading executives in the industrial sector who have the ability to qualify and introduce Labwire to contacts in our target markets. Their direct contacts alone easily represent $25-$40 million in approachable drug testing revenue. By utilizing these introductions, our sales and marketing teams can achieve much greater efficiency in their efforts. In addition to their contacts, our Board Member's knowledge of corporate structure and growth management should prove invaluable to Labwire as we rapidly grow over the next few years."
Drug screening has become an institutionalized employment practice as more than 85% of companies with over 100 employees have established drug screening policies. Employment screening has experienced steady and rapid growth over the past decade becoming a $3.5 - $5 billion industry. Labwire plans to continue to grow generically and through acquisitions of third party providers and is already one of the top revenue generating companies in the industry. Among its notable achievements, Labwire was awarded the largest contract in DOT (Department of Transportation) history in July 2004.
For corporate and product information, please visit www.labwire.com.
About Labwire
Labwire Inc., Headquartered in Houston, TX, provides secure and compliant employee drug screening and background checking services to Fortune 500 corporations via the Labwire(tm) Platform. Labwire(tm) is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.